The Priority Review

Tag

MAXONA Pharmaceuticals

1 story

Stories

  1. Clinical trials

    MAXONA announces first patient dosed in Phase 2 trial of MAX-001 for acute pain

    MAXONA Pharmaceuticals reported that the first participant was dosed in its Phase 2 clinical trial of MAX-001 for acute pain following surgical extraction of impacted third molars (NCT07937657). The study plans to enroll 276 patients and evaluate safety and efficacy across a dose range.